In August, Jimmy Carter was diagnosed with melanoma in his liver and brain. These lesions were addressed directly, he was put on Keytruda and now the former president is in remission. But since this new drug costs about $150,000 per year, we ask: Shouldn't we be talking about this? Continue reading
The post Jimmy Carter’s Remission Overlooks Cost of Cancer Drugs appeared first on American Council on Science and Health.